Eledon Pharmaceuticals Inc (ELDN)

11:44 AM

Eledon Shares Fall Nearly 50% After Phase 2 Results - Orange County Business Journal

11:44 AM

09:07 AM

What drives Eledon Pharmaceuticals Inc stock priceSwing Trading Ideas & Small Entry Cost Trading - earlytimes.in

09:07 AM

Nov 21, 2025

Midday Stock Roundup: RxSight up 14% - Orange County Business Journal

Nov 21, 2025

Nov 21, 2025

How analysts rate Eledon Pharmaceuticals Inc. stock todayWeekly Risk Summary & Growth Focused Stock Pick Reports - newser.com

Nov 21, 2025

Nov 20, 2025

Will Eledon Pharmaceuticals Inc. (2TK) stock test record highs in 20252025 Risk Factors & Long-Term Growth Portfolio Plans - newser.com

Nov 20, 2025

Nov 20, 2025

Is Eledon Pharmaceuticals Inc. (2TK) stock supported by strong fundamentalsJuly 2025 Closing Moves & High Return Stock Watch Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

Eledon Pharmaceuticals Reports Q3 2025 Financial Results - TipRanks

Nov 19, 2025

Nov 19, 2025

How analysts revise price targets for Eledon Pharmaceuticals Inc. (2TK) stockWeekly Trade Report & AI Forecasted Entry and Exit Points - newser.com

Nov 19, 2025

Nov 19, 2025

What technical patterns form on Eledon Pharmaceuticals Inc. (2TK) stock chartsWeekly Gains Report & Accurate Entry/Exit Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Is Eledon Pharmaceuticals Inc. (2TK) stock worth buying before Fed actionTrend Reversal & Free Safe Capital Growth Stock Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Eledon Pharmaceuticals Inc. stock momentum explainedEarnings Beat & Free Community Consensus Stock Picks - newser.com

Nov 19, 2025

Nov 19, 2025

Why Eledon Pharmaceuticals Inc. (2TK) stock could be top winnerEarnings Trend Report & Long-Term Growth Portfolio Plans - newser.com

Nov 19, 2025

Nov 19, 2025

Can Eledon Pharmaceuticals Inc. (2TK) stock sustain margin levelsJuly 2025 EndofMonth & Capital Protection Trading Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Eledon’s transplant rejection drug shows promise in Phase I/II diabetes trial - Clinical Trials Arena

Nov 19, 2025

Nov 19, 2025

Visual trend scoring systems applied to Eledon Pharmaceuticals Inc.Weekly Profit Recap & AI Driven Price Forecasts - newser.com

Nov 19, 2025

Nov 19, 2025

Market reaction to Eledon Pharmaceuticals Inc.’s recent newsTrade Signal Summary & Safe Capital Investment Plans - newser.com

Nov 19, 2025

Nov 19, 2025

Why Eledon Pharmaceuticals Inc. (2TK) stock stays on buy lists2025 Price Action Summary & Breakout Confirmation Alerts - newser.com

Nov 19, 2025

Nov 18, 2025

Eledon Pharmaceuticals stock rises after positive islet transplant data By Investing.com - Investing.com Australia

Nov 18, 2025

Nov 18, 2025

Eledon Pharmaceuticals stock rises after positive islet transplant data - Investing.com

Nov 18, 2025

Nov 18, 2025

Eledon’s anti-CD40L antibody shows promise in diabetes trial - Investing.com

Nov 18, 2025

Nov 18, 2025

Eledon reports preliminary data from first six patients with type 1 diabetes treated with tegoprubart as the core immunosuppressant - MarketScreener

Nov 18, 2025

Nov 18, 2025

Eledon Pharmaceuticals (ELDN) Reports Promising Trial Results fo - GuruFocus

Nov 18, 2025

Nov 18, 2025

Eledon Pharmaceuticals Reports Encouraging Preliminary Results for Tegoprubart in Islet Transplantation for Type 1 Diabetes - Quiver Quantitative

Nov 18, 2025

Nov 18, 2025

Eledon’s anti-CD40L antibody shows promise in diabetes trial By Investing.com - Investing.com Nigeria

Nov 18, 2025

Nov 18, 2025

Eledon (NASDAQ: ELDN) tegoprubart study: 6 T1D islet transplant patients insulin-free - Stock Titan

Nov 18, 2025

Nov 18, 2025

Guggenheim Lowers Price Target for ELDN While Maintaining Buy Ra - GuruFocus

Nov 18, 2025

Nov 18, 2025

Is Eledon Pharmaceuticals Inc. stock a buy in volatile marketsJuly 2025 Decliners & AI Optimized Trading Strategy Guides - newser.com

Nov 18, 2025

Nov 17, 2025

Transcript : Eledon Pharmaceuticals, Inc. Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference, Nov-12-2025 10 - MarketScreener

Nov 17, 2025